Publications by authors named "James Butera"

Claim this Profile
T
Transcriptomics of acute myeloid leukaemia core bone marrow biopsies reveals distinct therapy response-specific osteo-mesenchymal profiles.
Diana O Treaba, Dennis M Bonal, Anna Chorzalska, Mireia Castillo-Martin, Alissa Oakes, James Butera

Br J Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab as First-Line Therapy for B-Cell Lymphomas: A Phase I Study.
Thomas Ollila, James Butera, Pamela Egan, John Reagan, Anthony Thomas

Oncologist· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma.
Adam J Olszewski, Anna D Chorzalska, Max Petersen, Thomas A Ollila, Adam Zayac, James Butera

Blood Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrahepatic Cholangiocarcinoma in a Patient with Hepatitis C: A Cautionary Tale.
Soumitri Barua, Sophie Sprecht-Walsh, Zoe Weiss, James N Butera, Khaldoun Almhanna

R I Med J (2013)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of bendamustine- or cyclophosphamide-based first-line chemotherapy in older patients with indolent B-cell lymphoma.
Adam J Olszewski, James N Butera, John L Reagan, Jorge J Castillo

Am J Hematol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Amyloidosis Mimicking Lung Cancer.
Adam S Fisch, Florian J Fintelmann, Maria L Garcia-Moliner, Henning A Gaissert, Inga Lennes, James N Butera

Am J Respir Crit Care Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy.
Adam J Olszewski, Anna D Chorzalska, Annette S Kim, Peter J Quesenberry, Mary L Lopresti, James N Butera

Br J Haematol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new onset of thrombocytopenia and microangiopathic hemolytic anemia in the healthcare setting: A challenge for diagnosis.
Mengyang Di, Jessica Bian, James N Butera

Am J Hematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease.
Thomas A Ollila, Adam J Olszewski, James N Butera, Matthew I Quesenberry, Peter J Quesenberry

Clin Lymphoma Myeloma Leuk· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterozygous Hemoglobin Sherwood Forest Causing Polycythemia.
Vikram M Raghunathan, James N Butera, Diana O Treaba

Case Rep Hematol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low microchimeric cell density in tumors suggests alternative antineoplastic mechanism.
Timothy W Jolis, Brenna M Brucker, Christoph Schorl, James N Butera, Peter J Quesenberry

Med Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapies for Hemorrhagic Transformation in Acute Ischemic Stroke.
Joshua A Stone, Joshua Z Willey, Salah Keyrouz, James Butera, Ryan A McTaggart

Curr Treat Options Neurol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAFRO Syndrome Associated with EBV and Successful Triple Therapy Treatment: Case Report and Review of the Literature.
Malorie Simons, Emmanuel Apor, James N Butera, Diana O Treaba

Case Rep Hematol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryoglobulinemic membranoproliferative glomerulonephritis associated with mucosa-associated lymphoid tissue lymphoma treated with rituximab.
Austin Y Ha, Nicole Noronha, Patrick Gleason, Jonathan N Winkler, James N Butera

Clin Nephrol Case Stud· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetics and diffuse large B-Cell lymphoma.
Rabin Niroula, James Butera

R I Med J (2013)· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attending Physician Attitudes Toward Choice of Oral Anticoagulant for the Treatment of Venous Thromboembolism.
Nathan T Connell, James N Butera

R I Med J (2013)· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in the clinical course of heparin induced thrombocytopenia before and after the availability of HIT IgG class testing.
John L Reagan, Randall R Ingham, Samir Dalia, James N Butera, Joseph D Sweeney

Thromb Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype.
Peter S Nakhla, James N Butera, Diana O Treaba, Jorge J Castillo, Peter J Quesenberry

Leuk Lymphoma· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular immunotherapy for refractory hematological malignancies.
John L Reagan, Loren D Fast, Howard Safran, Martha Nevola, Eric S Winer, James N Butera

J Transl Med· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOP.
Jorge J Castillo, Natalie Sinclair, Brady E Beltrán, Moo-Kon Song, Ivana Ilic, James N Butera

Leuk Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis in primary effusion lymphoma is associated with the number of body cavities involved.
Jorge J Castillo, Helen Shum, Majid Lahijani, Eric S Winer, James N Butera

Leuk Lymphoma· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonengraftment haploidentical cellular therapy for hematologic malignancies.
John L Reagan, Loren D Fast, Eric S Winer, Howard Safran, James N Butera

Adv Hematol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP.
Jorge J Castillo, Brady E Beltran, Moo-Kon Song, Ivana Ilic, Sirpa Leppa, James N Butera

Leuk Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL.
John L Reagan, Alan Rosmarin, James N Butera, Ahmed Nadeem, Fred J Schiffman

Cancer Chemother Pharmacol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru.
Brady E Beltran, Jorge J Castillo, Domingo Morales, Fernando Hurtado de Mendoza, Pilar Quinones, James N Butera

Am J Hematol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis